DUBLIN, March 29, 2024 (GLOBE NEWSWIRE) — “Global DNA Methylation Detection Technology Market: Focus on Technologies, Applications, End Users, Product Types, Country Level Analysis and Competitive Landscape – Analysis and Forecasts , 2023-2033'' report was added to ResearchAndMarkets.com Recruitment.

The global DNA methylation detection technology market is projected to experience significant growth over the forecast period 2023-2033. Moreover, the market value was $2.8 billion in 2023 and is expected to reach $12.32 billion by 2033, growing at a CAGR of 15.96%.

This growth can be attributed to increased adoption of DNA methylation detection techniques as epigenetic biomarkers, increased collaboration between academic institutions, and an increase in start-ups in the biotechnology and pharmaceutical industries. The market includes a variety of consumables, equipment, and software.

In the DNA methylation detection technology market, several major players dominate the market with diverse products and solutions. Thermo Fisher Scientific, Illumina, Inc., QIAGEN, Zymo Research Corporation, and Agilent Technologies, Inc. are among the prominent market players offering innovative tools and platforms for DNA methylation analysis. These companies provide bisulfite conversion kits, methylation-specific PCR assays, microarray platforms, next-generation sequencing solutions, and bioinformatics software to researchers and clinicians around the world.

Competition in this market is intense, driven by continued technological innovation, expanding product portfolios, effective marketing strategies, and a focus on regulatory compliance. Moreover, market players are competing for market share by establishing strong customer support networks and ensuring high-quality service delivery. As the demand for DNA methylation detection technology increases, competition intensifies and companies strive to remain competitive in the market while meeting the evolving needs of the research and clinical communities.

In 2022, the global DNA methylation detection technology market was dominated by North America. Furthermore, Asia Pacific is expected to register the highest CAGR of 17.79% during the forecast period 2023-2033. The DNA methylation detection technology market in the Asia Pacific (APAC) region is witnessing significant growth due to various factors such as rising investments in epigenetics and biotechnology, and population base driving diagnostic demand.

Market life cycle stages

The global DNA methylation detection technology market can be considered to be at a mature growth stage of its life cycle. This stage is characterized by rapid market expansion driven by the increasing adoption of DNA methylation analysis tools and techniques in both research and clinical settings.

Increasing understanding of the role of DNA methylation in various biological processes and diseases, coupled with advances in detection methods and analytical platforms, will drive market growth. Moreover, the growing demand for personalized medicine and high-precision diagnostics is further accelerating the market expansion. While competition increases as more players enter the market, opportunities for innovation, product development, and market penetration abound.

Impact on the industry

The global DNA methylation detection technology market has had a significant impact on various industries, revolutionizing healthcare, biotechnology, pharmaceuticals, and research. These technologies enable advanced precision medicine approaches by enabling the identification of epigenetic biomarkers associated with disease susceptibility, progression, and treatment response, and provide insight into the genetic and epigenetic profile of individual patients. enables personalized treatment strategies.

In drug discovery and development, DNA methylation analysis accelerates the identification of new drug targets, biomarkers for patient stratification, and predictors of drug response, leading to the development of more effective and safer treatments. Masu. Furthermore, these technologies are increasingly used in clinical diagnostics for the early detection, diagnosis, and prognosis of diseases, providing high sensitivity and specificity to improve patient outcomes.

The global DNA methylation detection technology market continues to drive innovative advances across industries, with far-reaching implications for human health and environmental sustainability.

Consumables dominate global DNA methylation detection technology market (by product)

On a product basis, the consumables segment dominated the global DNA methylation detection technology market in FY2022. The recurring need for consumables such as bisulfite conversion kits, PCR reagents, and sequencing libraries will increase ongoing demand. Second, there is increasing adoption of high-throughput methods such as next-generation sequencing and microarray analysis, which require large amounts of consumables to efficiently process samples. Moreover, as the research and clinical applications of DNA methylation analysis expand, the demand for consumables is expected to steadily increase, further solidifying its market dominance.

PCR maintains dominance in global DNA methylation detection technology market (by technology)

On a technology basis, the PCR segment accounted for the largest share in the global DNA methylation detection technology market in FY2022. Furthermore, PCR is expected to maintain its dominance in the global DNA methylation detection technology market by technology due to its widespread adoption, versatility, and reliability. PCR-based methods such as methylation-specific PCR (MSP) and quantitative real-time PCR (qPCR) have high sensitivity and specificity for detecting DNA methylation patterns, making them useful in epigenetic research and clinical diagnosis. It has become an essential tool.

Diagnostic procedures to maintain dominance in the global DNA methylation detection technology market (by application)

Based on application, diagnostic research accounted for the largest share in the global DNA methylation detection technology market in 2022. This is mainly because clinicians are focusing on using DNA methylation analysis for clinical diagnosis. DNA methylation patterns have been widely studied as potential biomarkers for various diseases such as cancer, neurological disorders, and autoimmune diseases.

Biopharmaceutical and biotechnology companies segment maintains dominance in global DNA methylation detection technology market (by end user)

On an end-user basis, the biopharmaceutical and biotechnology companies segment extensively uses DNA methylation analysis in drug discovery, development, and personalized medicine applications, thus contributing to the global DNA methylation detection technology market in FY2022. accounted for the largest share.

Key attributes:

report attributes detail
number of pages 109
Forecast period 2023-2033
Estimated market value in 2023 (USD) $2.8 billion
Projected market value to 2033 (USD) $12.32 billion
compound annual growth rate 15.9%
Target area global

Industry overview

Trends: Current and future impact assessments

  • Bisulfite conversion as the gold standard in the global DNA methylation detection technology market
  • Expanding DNA methylation detection technology for clinical research applications

market drivers

  • Increasing adoption of DNA methylation detection techniques as epigenetic biomarkers
  • Increased research and development in genomics and epigenetics
  • Technological advances in detection methods

market constraints

  • Complexity of data interpretation of DNA methylation data
  • Expensive DNA methylation detection equipment and various kits and assays

market opportunity

  • DNA methylation detection technology as an early diagnosis tool for diseases
  • Expanding DNA methylation detection in emerging regions

Supply chain overview

  • value chain analysis
  • market map

Research and development review

  • Patent application trends (by country and company)
  • Regulatory status

Impact analysis of major global events – COVID-19

Overview of key market players and competition

  • Agilent Technologies Co., Ltd.
  • Abcam Ltd.
  • Bio-Rad Laboratories, Inc.
  • Illumina Co., Ltd.
  • Qiagen NV
  • Thermo Fisher Scientific
  • F. Hoffman La Roche Co., Ltd.
  • Hologic Co., Ltd.
  • Pacific Biosciences of California, Inc.
  • Exact Science Co., Ltd.
  • Merck KGaA
  • Enzo Life Sciences
  • Takara Bio Co., Ltd.
  • Revvity, Inc. (PerkinElmer)
  • new england bio lab

Report scope

application

Global DNA methylation detection technology market (by technology)

  • Polymerase chain reaction (PCR)
  • microarray
  • sequence
  • Other technologies

Global DNA methylation detection technology market (by application)

  • translational research
  • Diagnostic procedure

Global DNA methylation detection technology market (by end user)

  • Contract Research Organization (CRO)
  • Research and academic institutions
  • Biopharmaceutical and biotechnology companies
  • Other end users

product

product segmentation

  • Product Summary
  • Product type
  • Market overview
  • Analyst view

Global DNA Methylation Detection Technology Market (by Product Type)

  • consumables
  • Kits and assays
  • reagent
  • enzyme
  • musical instrument
  • software

For more information on this report, please visit https://www.researchandmarkets.com/r/kw45y9.

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide the latest data on international and regional markets, key industries, top companies, new products and latest trends.

  • Global DNA methylation detection technology market


            



Source link